ニュース

MassDevice7 日
FDA approves Abbott mitral valve replacement device that doesn’t require open-heart surgery
Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...
TCTMD5 日
Tendyne Approved in US for High-risk Patients With Mitral Valve Disease
The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...
Investing.com6 日
アボットのTendyne弁、僧帽弁置換術でFDA承認を取得
イリノイ州アボットパーク - ヘルスケア機器・用品業界の主要企業であり、時価総額2,280億ドルを誇るアボット・ラボラトリーズ（NYSE: ABT）は、Tendyne経カテーテル僧帽弁置換（TMVR）システムについて米国食品医薬品局（FDA）の承認を取得した。この装置は ...
Fierce Biotech7 日
Abbott snags US approval for Tendyne mitral valve replacement implant
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
Abbott Gains FDA Approval for Tendyne™, Strengthening Its Minimally Invasive Heart Portfolio
Abbott Laboratories (NYSE:ABT) has received FDA approval today for its Tendyne™ transcatheter mitral valve replacement (TMVR) ...
ADVFN2 日
Abbott Receives FDA Approval for Tendyne™, First-of-Its-Kind Device to Replace the Mitral ...
May 27, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR ...
Investing7 日
Abbott’s Tendyne valve gets FDA nod for mitral replacement
The Tendyne system is designed for those who are considered high-risk for traditional open-heart surgery and for whom mitral valve repair with Abbott’s MitraClip is not a viable option.
Investing7 日
Abbott’s Tendyne valve gets FDA nod for mitral replacement
ABBOTT PARK, Ill. - Abbott Laboratories (NYSE: ABT), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $228 billion, has received approval from the U.S ...